BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33472196
Number of visits today
7094
Number of downloads
16655900
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Meijboom RW, Gardarsdottir H, Egberts TCG, Giezen TJ. Patients Retransitioning from Biosimilar TNFα Inhibitor to the Corresponding Originator After Initial Transitioning to the Biosimilar: A Systematic Review. BioDrugs 2021. [PMID: 34870802 DOI: 10.1007/s40259-021-00508-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Meijboom RW, Barbier L, Druedahl LC, Sarnola K, Tolonen HM, Gardarsdottir H, Egberts A, Giezen TJ. Recommendations on TNFα inhibitor biosimilar use in clinical practice: a comparison of European gastroenterology IBD guidance. Expert Opin Biol Ther 2023. [PMID: 36947408 DOI: 10.1080/14712598.2023.2189008] [Reference Citation Analysis]
2 Jourdain H, Hoisnard L, Sbidian E, Zureik M. TNF-alpha inhibitors biosimilar use in France: a nationwide population-based study using the French National Health Data System. Sci Rep 2022;12:19569. [PMID: 36380105 DOI: 10.1038/s41598-022-24050-7] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345